|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.875 SEK | +1.63% |
|
+1.08% | -1.32% |
| 20/07 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 16/07 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 45Cr 39Cr 36Cr 33Cr 62Cr 4.26TCr 63Cr 424.44Cr 166.59Cr 2.14TCr 168.18Cr 164.49Cr 7.06TCr | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 42Cr 36Cr 34Cr 31Cr 58Cr 3.96TCr 59Cr 394Cr 154.65Cr 1.98TCr 156.12Cr 152.7Cr 6.56TCr | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.63% | ||
| 1 week | +1.08% | ||
| Current month | +1.08% | ||
| 1 month | -20.21% | ||
| 3 months | -30.56% | ||
| 6 months | +2.74% | ||
| Current year | -1.32% |
| 1 week | 1.78 |  | 1.91 |
| 1 month | 1.61 | | 2.6 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 13.4 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 01/01/2011 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% | ||
| 27/12/25 | Buy | Chairman | 30,000 | 0.0124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.63% | +1.08% | -30.30% | -33.63% | 4.71Cr | |
| -0.67% | +2.80% | +84.28% | +160.09% | 1,06200Cr | |
| +0.22% | +0.26% | +49.83% | +48.47% | 62TCr | |
| +0.67% | -2.43% | +23.12% | +62.87% | 43TCr | |
| +0.71% | +3.87% | +47.45% | +38.68% | 36TCr | |
| +0.64% | -0.49% | +35.39% | +40.21% | 29TCr | |
| +0.39% | -5.83% | +8.64% | +9.28% | 25TCr | |
| +1.24% | +6.12% | +43.57% | +61.60% | 22TCr | |
| +3.92% | -0.46% | -1.21% | -44.09% | 20TCr | |
| +1.93% | +2.27% | +20.76% | +65.08% | 16TCr | |
| Average | +1.16% | -1.95% | +28.15% | +40.86% | 35.92TCr | |
| Weighted average by Cap. | +0.54% | -0.83% | +48.03% | +75.25% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.56Cr 3.94Cr 3.68Cr 3.38Cr 6.35Cr 433.75Cr 6.45Cr 43Cr 17Cr 217.4Cr 17Cr 17Cr 718.73Cr | 5.39Cr 4.66Cr 4.35Cr 3.99Cr 7.51Cr 513Cr 7.63Cr 51Cr 20Cr 257.13Cr 20Cr 20Cr 850.06Cr |
| Net income | -5.32Cr -4.6Cr -4.3Cr -3.94Cr -7.41Cr -506.11Cr -7.53Cr -50Cr -20Cr -253.68Cr -20Cr -20Cr -838.64Cr | -5.19Cr -4.49Cr -4.19Cr -3.85Cr -7.23Cr -493.85Cr -7.35Cr -49Cr -19Cr -247.53Cr -19Cr -19Cr -818.32Cr |
| Net Debt | -7.3Cr -6.32Cr -5.9Cr -5.41Cr -10Cr -694.86Cr -10Cr -69Cr -27Cr -348.28Cr -27Cr -27Cr -1.15TCr | -3.21Cr -2.78Cr -2.59Cr -2.38Cr -4.48Cr -305.61Cr -4.55Cr -30Cr -12Cr -153.18Cr -12Cr -12Cr -506.4Cr |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | SEK 1.875 | +1.63% | 50,964 |
| 06/26/06 | SEK 1.845 | +0.54% | 57,243 |
| 05/26/05 | SEK 1.835 | -3.42% | 79,704 |
| 04/26/04 | SEK 1.900 | 0.00% | 21,962 |
| 03/26/03 | SEK 1.900 | +2.43% | 32,162 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
